Thursday, June 26
Session 3B: 1:30 -2:30 PM
Fellows’ room: learn from the Editors of Journals
Moderators: Stuart Spencer (Brenzett, GBR), Harriette Van Spall (Hamilton, CAN)
Master tips to convince the reviewers – Arianna Colosio (Lancet Respiratory Medicine, GBR) Figures are key – Christian Jung (Düsseldorf, DEU) What matters in the statistical review – Michael Harhay (Pennsylavia, USA) My advice to answer to reviewers – Biykem Bozkurt (Houston, USA)
Panel discussion with all the above
Friday, June 27
Session 6B: 8:30- 10:00 AM
Preventing renal damage in the critically ill: a transdisciplinary effort!
Moderators: Pascal LePrince (Paris, FRA)
How to prevent AKI in ICU? - Marlies Ostermann (London, GBR) Main drivers of AKI – Rafael Kramann (Aachen, DEU) Sub-clinical AKI: a new entity with high risk – Matthieu Legrand (San Francisco, USA) Lessons from Dan-Ger shock trial? – Erlic Zweck (Düsseldorf, DEU) Trail design to assess therapies that prevent worsening AKI – Peter Pickkers (Nijmegen, NLD) Post-discharge management after AKI – François Depret (Paris, FRA) Industry Perspective - Abiomed, AM-Pharma Regulator Perspective
Panel discussion with all the above
Fellows in charge of the scientific paper - François Depret (Paris, FRA), Elric Zweck (Düsseldorf, DEU)
Session 7B : 10:30 AM - 12:00 PM
How to design an escalating dose in critical care?
Moderators: Alexandre Mebazaa (Paris, FRA), Harriette Van Spall (Hamilton, CAN)
Phase 2 is not a "small" phase 3 trial – Harriette Van Spall (Hamilton, CAN) Bayesian adaptive two-stage design – Anastasia Ivanova (Chapel Hill, USA) Statistical thoughts on phase 2 trials in critical care – Janet Wittes (Washington, USA) Learning from recent phase 2 trials in ICU – Michael Harhay (Pennsylavia, USA) Industry perspective - Bayer, Jens-Peter Marschner (4Teen4, DEU)
Panel discussion with all the above
Session 8B : 1:00 - 3:00 PM
Assessing congestion in heart failure: tools are already available
Moderators: Nicolas Girerd (Nancy, FRA), Maria Rosa Costanzo (Naperville, USA), Naoki Sato (Tokyo, JPN)
Is there a gold standard to assess congestion? – Marat Fudim (Durham, USA) Inferior vena cava diameters – Mandeep Mehra (Boston, USA) Liver stiffness – Jan Biegus (Wrocław, POL) Assessing congestion at home: COSI-HOME study – Alexandre Mebazaa (Paris, FRA) Monitoring pulmonary artery pressure – Maria Rosa Costanzo (Naperville, USA) AI helps me triaging congestive patients – TBCPatients are ready to act – Nick Hartshorne-Evans (Preston, GBR) Industry Perspective - Echosens, Juuso Blomster (CardioSignal) Patient are ready to act - Nick Hartshorne - Evans (Preston, GRB)
Panel discussion with all the above
In charge of the scientific paper - Jolie Bruno (Berne, CHE), Nicolas Girerd (Paris, FRA)
Session 9B: 3:30 - 5:00 PM
Round table: Time for a Global CS collaboratory?
Moderators: Sabri Soussi (Toronto, CAN), Susanna Price (London, GBR), Shashank Sinha (Falls Church, USA), Naoki Sato (Tokyo, JPN)
Biobanking is key in CS collaborative research – Phyllis Billia (Toronto, CAN) Clinical trials in CS research – Rebecca Mathew (Ottawa, CAN) Network of networks in CS research: the ShockCO-OP consortium initiative – Sabri Soussi (Toronto, CAN) Data sharing – Naoki Sato (Tokyo, JPN) Omics-based biomarkers in CS research – Alastair Proudfoot (London, GBR) Urgent need for cardiac arrest trials – Shir Lynn Lim (Singapore, SGP)
